New details about Plymouth Meeting firm’s IPO plans reveal value could approach $107M
August 14, 2020 at 13:16 PM EDT
The biopharmaceutical company set a per-share price range between $20 and $23 for its initial public offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.